Related Experiment Videos
Infective endocarditis, rheumatoid factor, and anticardiolipin antibodies.
R A Asherson1, M Tikly, H Staub
1Lupus Arthritis Research Unit, Rayne Institute, St Thomas's Hospital, London.
Annals of the Rheumatic Diseases
|February 1, 1990
Summary
Infective endocarditis patients showed low prevalence of anticardiolipin antibodies and discordance with rheumatoid factor and VDRL tests. No thrombotic events were observed, suggesting distinct antibody production pathways.
Area of Science:
- Immunology
- Infectious Diseases
- Rheumatology
Background:
- Infective endocarditis is a serious infection affecting heart valves.
- Anticardiolipin antibodies and rheumatoid factor are sometimes associated with infections and autoimmune conditions.
- The Venereal Disease Research Laboratory (VDRL) test is used for syphilis detection but can yield false positives.
Purpose of the Study:
- To determine the prevalence and levels of anticardiolipin antibodies in patients with infective endocarditis.
- To assess the correlation between anticardiolipin antibodies, rheumatoid factor, and VDRL test results in these patients.
- To investigate the distinctness of B cell antibody production in infective endocarditis.
Main Methods:
- Serum samples from 22 infective endocarditis patients were analyzed.
- Tests included detection of antibodies to cardiolipin, rheumatoid factor (latex test), and VDRL.
- Prevalence, antibody levels, and correlations were statistically evaluated.
Main Results:
- Anticardiolipin antibodies were elevated in only 18% of patients, often at low levels.
- The VDRL test was positive in two patients with negative results for other antibodies.
- A clear discordance was observed between anticardiolipin antibodies, rheumatoid factor, and VDRL test results.
Conclusions:
- The production of anticardiolipin antibodies, rheumatoid factor, and VDRL reactivity appears to be separate and distinct in infective endocarditis.
- Elevated anticardiolipin antibodies are not consistently found in infective endocarditis.
- No thrombotic events were reported in the study cohort, aligning with findings in other infections associated with anticardiolipin antibodies.